REQUEST A DEMO
Total
USD $0.00
Search more companies

Neopharm Co.,Ltd. (South Korea)

Main Activities: Toilet Preparation Manufacturing
Full name: Neopharm Co.,Ltd. Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Neopharm Co.,Ltd. is based in South Korea. The head office is in Daejeon. The enterprise currently operates in the Toilet Preparation Manufacturing sector. The enterprise was incorporated on July 01, 2000. 171 (2024) employees currently work for Neopharm Co.,Ltd.. There was a net sales revenue increase of 11.07% reported in Neopharm Co.,Ltd.’s latest financial highlights for 2025. There was a total growth of 13.18% in Neopharm Co.,Ltd.’s total assets over the same period. The enterprise’s net profit margin increased by 1.67% in 2025.

Headquarters
928 Taplip-Dong, Yooseong-Gu
Daejeon; Daejeon; Postal Code: 305-510

Contact Details: Purchase the Neopharm Co.,Ltd. report to view the information.

Website: http://www.neo-pharm.co.kr

Basic Information
Total Employees:
Purchase the Neopharm Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Neopharm Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Neopharm Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Neopharm Co.,Ltd. report to view the information.
Incorporation Date:
July 01, 2000
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
37.23%
Purchase this report to view the information.
13.4%
Purchase this report to view the information.
8.76%
Purchase this report to view the information.
8.12%
Purchase this report to view the information.
4.39%
Subsidiaries
Neopharm(Huzhou)Trading Co Ltd (China)
Neopharm(Shanghai)Trading Co Ltd (China)
Company Performance
Financial values in the chart are available after Neopharm Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
11.07%
Total Operating Revenue
11.17%
Operating Profit
20.74%
EBITDA
15.06%
Net Profit/Loss for the Period
20.63%
Total Assets
13.18%
Total Equity
10.44%
Operating Profit Margin
1.75%
Net Profit Margin
1.67%
Return on Equity (ROE)
1.2%
Debt / Equity
0.62%
Quick Ratio
-1.63%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?